SRC and breast cancer: Moreover, phosphorylation of EndoA2-Tyr315 by Src, which inhibits MT1-MMP endocytosis and increases ECM degradation [125], also accelerates tumor progression in a murine breast cancer model by promoting epithelial-mesenchymal transition and mammary cancer stemness [193].